Sana Biotechnology SANA
NASDAQ SANA
$3.85 -0.07 (-1.79%)
As of: Sep 4, 2026 · 3:59 PM EDT

Sana Biotechnology (SANA) Sales of Property, Plant and Equipment (2025 - 2026)

Analysis

Sana Biotechnology (SANA) Sales of Property, Plant and Equipment (2025 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Sales of Property, Plant and Equipment (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 5.85 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Sana Biotechnology 1.14 Bn 1.14 Bn - 23,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 23,000.00
Mar 31, 2026 248,000.00
Dec 31, 2025 661,000.00
Sep 30, 2025 136,000.00
Jun 30, 2025 382,000.00
Mar 31, 2025 253,000.00